Source credit: PubMed / Journal of the International Society of Sports Nutrition – Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis.
Summary: A systematic review and meta-analysis published online May 16, 2026 pooled seven randomized trials in postmenopausal women and found that creatine monohydrate produced small but meaningful improvements in lean mass and leg-press strength, especially when doses of at least 5 grams per day were combined with resistance training. The review did not find a clear overall bone-density benefit, and trials using lower creatine doses without training did not show the same effect.
Why it matters for lifters
- This is a useful specificity check: The apparent benefit came from creatine plus lifting, not from treating creatine like a stand-alone shortcut.
- The upside looked modest, not magical: The paper supports creatine as a helpful add-on for some women in this population, but it does not justify overselling it as a cure-all for muscle loss or bone loss after menopause.
- Bone claims still need restraint: Many supplement pitches blur muscle, strength, and bone outcomes together. This review found the muscle and strength story was clearer than the bone-density story.
What to watch next
- Watch for larger preregistered trials that use consistent creatine dosing and standardized lifting programs.
- Watch for whether future studies clarify who benefits most by training age, protein intake, and years since menopause.
- If a supplement ad promises creatine alone will fix postmenopausal bone loss, compare that claim with this review’s more limited findings.
Health disclaimer: This article is for informational purposes only and is not medical advice. Supplement use, kidney concerns, medication interactions, and menopause-related health decisions should be discussed with a qualified clinician.